Date: 26 Nov 2012
Comparative Outcomes of Laparoscopic and Open Adrenalectomy for Adrenocortical Carcinoma: Single, High-Volume Center Experience
- Maria C. Mir MD, PhD,
- Joseph C. Klink MD,
- Julien Guillotreau MD,
- Jean-Alexandre Long MD, PhD,
- Ranko Miocinovic MD,
- Jihad H. Kaouk MD,
- Matthew N. Simmons MD, PhD,
- Eric Klein MD,
- Venkatesh Krishnamurthi MD,
- Steven C. Campbell MD, PhD,
- Amr F. Fergany MD,
- Jordan Reynolds MD,
- Andrew J. Stephenson MD,
- Georges-Pascal Haber MD, PhD
- … show all 14 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Adrenocortical carcinoma (ACC) is a rare and clinically aggressive cancer. Previous studies reported increased recurrence rates associated with laparoscopic adrenalectomy (LA). We evaluated a single-center experience of LA versus open adrenalectomy (OA) for the management of ACC.
Between 1993 and 2011, 44 consecutive patients with primary ACC were treated at our institution. Baseline patient characteristics and surgical and pathological outcomes were compared between OA and LA groups. Multivariable Cox proportional hazards analysis was used to estimate the association between OA versus LA with recurrence-free and overall survival.
Eighteen and 26 patients underwent LA and OA, respectively. Patients who underwent OA had larger tumors and more advanced clinical stage compared with LA group. During a median follow-up of 22 months, 22 recurrences and 26 deaths were observed. The 2-year, recurrence-free and overall survivals for OA and LA were 60 vs. 39 % (P = 0.7) and 54 vs. 58 % (P = 0.6), respectively. After adjusting for clinical stage, OA was associated with lower risk of recurrence (hazard ratio (HR) 0.4; 95 % confidence interval (CI) 0.2–1.2; P = 0.099) and improved overall survival (HR 0.5; 95 % CI 0.2–1.2; P = 0.122) compared with LA, although differences were not statistically significant.
A nonstatistically significant increase in recurrence and death was observed among patients undergoing LA versus OA after adjusting for clinical stage. The rarity of this disease limits the ability to assess for significant differences in a single-institution series. Patients with suspected ACC should be considered for OA.
Prinz RA. A comparison of laparoscopic and open adrenalectomies. Arch Surg. 1995;130(5):489–92; discussion 92–4.
Lee J, El-Tamer M, Schifftner T, Turrentine FE, Henderson WG, Khuri S, et al. Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program. J Am Coll Surg. 2008;206(5):953–9; discussion 9–61.
Gonzalez RJ, Shapiro S, Sarlis N, Vassilopoulou-Sellin R, Perrier ND, Evans DB, et al. Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery. 2005;138(6):1078–85; discussion 85–6.
Guz BV, Straffon RA, Novick AC. Operative approaches to the adrenal gland. Urol Clin North Am. 1989;16(3):527–34.PubMed
Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. Endocr Pract. 2009;15(5):450–3.PubMed
Guerrieri M, De Sanctis A, Crosta F, Arnaldi G, Boscaro M, Lezoche G, et al. Adrenal incidentaloma: surgical update. J Endocrinol Invest. 2007;30(3):200–4.PubMed
- Comparative Outcomes of Laparoscopic and Open Adrenalectomy for Adrenocortical Carcinoma: Single, High-Volume Center Experience
Annals of Surgical Oncology
Volume 20, Issue 5 , pp 1456-1461
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Maria C. Mir MD, PhD (1)
- Joseph C. Klink MD (1)
- Julien Guillotreau MD (1)
- Jean-Alexandre Long MD, PhD (1)
- Ranko Miocinovic MD (1)
- Jihad H. Kaouk MD (1)
- Matthew N. Simmons MD, PhD (1)
- Eric Klein MD (1)
- Venkatesh Krishnamurthi MD (1)
- Steven C. Campbell MD, PhD (1)
- Amr F. Fergany MD (1)
- Jordan Reynolds MD (2)
- Andrew J. Stephenson MD (1)
- Georges-Pascal Haber MD, PhD (1)
- Author Affiliations
- 1. Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
- 2. Pathology Molecular Institute, Cleveland Clinic, Cleveland, OH, USA